Current Environment: Production

Youyang Yang | Medical Services

Programs & Services

Languages

  • English

Youyang Yang | Education

Undergraduate School

Harvard University

Cambridge, MA

Medical School

University of Massachusetts Medical School

Worcester, MA

Internship

Pediatrics

Massachusetts General Hospital

Boston, MA

Residency

Pediatrics

Massachusetts General Hospital

Boston, MA

Fellowship

Critical Care Medicine

Boston Children's Hospital

Boston, MA

Youyang Yang | Certifications

  • American Board of Pediatrics (Critical Care Medicine)
  • American Board of Pediatrics (General)

Youyang Yang | Publications

  1. Using Implementation Science to Assess Barriers to Agreement on Sedation Goal Setting and Assessment. Pediatr Crit Care Med. 2025 Jan 01; 26(1):e51-e61. View Using Implementation Science to Assess Barriers to Agreement on Sedation Goal Setting and Assessment. Abstract

  2. Failure Modes and Effects Analysis to Evaluate Discharge Delays of Postoperative Tonsillectomy Patients From the Medical-Surgical PICU. J Pediatr Health Care. 2025 Jan-Feb; 39(1):58-68. View Failure Modes and Effects Analysis to Evaluate Discharge Delays of Postoperative Tonsillectomy Patients From the Medical-Surgical PICU. Abstract

  3. Comparing the Quality of Domain-Specific Versus General Language Models for Artificial Intelligence-Generated Differential Diagnoses in PICU Patients. Pediatr Crit Care Med. 2024 Jun 01; 25(6):e273-e282. View Comparing the Quality of Domain-Specific Versus General Language Models for Artificial Intelligence-Generated Differential Diagnoses in PICU Patients. Abstract

  4. Medication Errors: Detection Methodology Matters. J Patient Saf. 2024 03 01; 20(2):e6-e7. View Medication Errors: Detection Methodology Matters. Abstract

  5. Implementation Science in Pediatric Critical Care - Sedation and Analgesia Practices as a Case Study. Front Pediatr. 2022; 10:864029. View Implementation Science in Pediatric Critical Care - Sedation and Analgesia Practices as a Case Study. Abstract

  6. Implementation of an Analgesia-Sedation Protocol Is Associated With Reduction in Midazolam Usage in the PICU. Pediatr Crit Care Med. 2021 10 01; 22(10):e513-e523. View Implementation of an Analgesia-Sedation Protocol Is Associated With Reduction in Midazolam Usage in the PICU. Abstract

  7. "Closing the chasm" - guidelines bridge the gap from evidence to implementation. Pediatr Investig. 2021 Sep; 5(3):163-166. View "Closing the chasm" - guidelines bridge the gap from evidence to implementation. Abstract

  8. AML presenting with a preleukemic episode and acquired heterochromia in a child with macrosomia. Pediatr Blood Cancer. 2018 04; 65(4). View AML presenting with a preleukemic episode and acquired heterochromia in a child with macrosomia. Abstract

  9. A Case of Exertional Rhabdomyolysis: A Cheer for Standardizing Inpatient Management and Prevention. Hosp Pediatr. 2016 12; 6(12):753-756. View A Case of Exertional Rhabdomyolysis: A Cheer for Standardizing Inpatient Management and Prevention. Abstract

  10. A SALL4/MLL/HOXA9 pathway in murine and human myeloid leukemogenesis. J Clin Invest. 2013 Oct; 123(10):4195-207. View A SALL4/MLL/HOXA9 pathway in murine and human myeloid leukemogenesis. Abstract

  11. Akt phosphorylates the transcriptional repressor bmi1 to block its effects on the tumor-suppressing ink4a-arf locus. Sci Signal. 2012 Oct 23; 5(247):ra77. View Akt phosphorylates the transcriptional repressor bmi1 to block its effects on the tumor-suppressing ink4a-arf locus. Abstract

  12. SALL4 is a key transcription regulator in normal human hematopoiesis. Transfusion. 2013 May; 53(5):1037-49. View SALL4 is a key transcription regulator in normal human hematopoiesis. Abstract

  13. The ability of MLL to bind RUNX1 and methylate H3K4 at PU.1 regulatory regions is impaired by MDS/AML-associated RUNX1/AML1 mutations. Blood. 2011 Dec 15; 118(25):6544-52. View The ability of MLL to bind RUNX1 and methylate H3K4 at PU.1 regulatory regions is impaired by MDS/AML-associated RUNX1/AML1 mutations. Abstract

  14. SALL4, a stem cell factor, affects the side population by regulation of the ATP-binding cassette drug transport genes. PLoS One. 2011 Apr 19; 6(4):e18372. View SALL4, a stem cell factor, affects the side population by regulation of the ATP-binding cassette drug transport genes. Abstract

  15. Stem cell factor SALL4 represses the transcriptions of PTEN and SALL1 through an epigenetic repressor complex. PLoS One. 2009; 4(5):e5577. View Stem cell factor SALL4 represses the transcriptions of PTEN and SALL1 through an epigenetic repressor complex. Abstract

BESbswy